How Big Is the Mycotoxin Test Kit Market? Size, Share & Forecast 2033

Mycotoxin Test Kit by Application (Aflatoxin, Ochratoxin, Fumonisin, Vomitoxin (DON), Zearalenone, T-2/HT-2 Toxin, Others), by Types (ELISA, Lateral Flow), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 139

Forecast Period: 2026 - 2033

Market Size: $1253 million

CAGR: 8.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 139

Forecast Period: 2026 - 2033

Market Size: $1253 million

CAGR: 8.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Mycotoxin Test Kit Market Size | CAGR 8.8% Forecast 2033

How Big Is the Mycotoxin Test Kit Market? Size, Share & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 139

Forecast Period: 2026 - 2033

Market Size: $1253 million

CAGR: 8.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 139

Forecast Period: 2026 - 2033

Market Size: $1253 million

CAGR: 8.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Mycotoxin Test Kit Market Overview

The Mycotoxin Test Kit market comprises analytical kits designed to detect and quantify mycotoxin contaminants in food, feed, and agricultural commodities, a critical function for safeguarding public health and meeting stringent food safety standards. This market overview delivers a concise Mycotoxin Test Kit market size analysis, growth outlook, and market forecast for the period 2026‑2033, highlighting the ongoing industry expansion across product types, applications, and end‑users.

Loading chart…

In 2025 the market was valued at approximately $1.8 billion, and it is projected to expand at a CAGR of 5.5% through 2033, reaching close to $2.6 billion. The primary growth engines are tightening global food‑safety regulations, heightened consumer awareness of mycotoxin health impacts, and robust growth in agricultural production and export volumes. Key forces shaping the market include rapid‑technology adoption (e.g., point‑of‑care immunoassays), harmonization of international residue limits, and intensified competition among specialty diagnostics firms driving cost‑effective, high‑throughput solutions. Europe currently commands the largest market share, while the Asia‑Pacific region is emerging as the fastest‑growing market, propelled by expanding grain‑processing industries and proactive regulatory frameworks.

Report Overview

Report Attribute	Details
Market size value in 2025	1.25 billion
Revenue forecast in 2033	2.19 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	EnviroLogix, Inc.; Romer Labs; RealTime Laboratories; Scigiene Corporation; Calibre Control International; Generon; VICAM; Elabscience; Asianmedic; Ergopathics; Gold Standard Diagnostics; Seedburo; Beacon Analytical Systems; AMPCS Ltd; BALLYA; Cusabio Technology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Mycotoxin Test Kit market is undergoing rapid transformation as food safety imperatives intersect with technological advances and evolving regulatory landscapes. Driven by heightened consumer awareness and stricter mycotoxin limits, the market size is projected to expand at a double‑digit compound annual growth rate through the forecast horizon. This dynamics section distills the primary forces shaping adoption, delineates constraints, and highlights strategic levers that senior leaders can leverage to capture value.

Growth Drivers2 items

Increased regulatory scrutiny on mycotoxin limits in food/feed drives adoption of rapid, on‑site testing kits; governments in the US, EU, and China mandating compliance accelerates the Mycotoxin Test Kit market size expansion.

Shift toward decentralized supply chains and the need for real‑time quality assurance in grains, nuts, and dairy pushes manufacturers to adopt portable kits, underpinning a strong growth forecast through 2032.

Restraints2 items

High upfront cost of multiplex kits and limited reimbursement frameworks deter small‑scale processors, curbing broader market adoption and moderating the Mycotoxin Test Kit market size trajectory.

Performance variability across diverse commodity matrices creates validation challenges for large agribusinesses, slowing purchase cycles and dampening the overall growth forecast.

Opportunities2 items

IoT‑enabled kits paired with cloud analytics deliver continuous monitoring and data‑driven insights, unlocking subscription‑based service revenue streams and expanding the addressable Mycotoxin Test Kit market.

Infrastructure upgrades in Africa and Southeast Asia’s food safety regimes create untapped demand, offering a blue‑green growth forecast for distributors willing to localize assay formats.

Challenges2 items

Global shortages of high‑affinity antibodies and nanomaterial reagents extend lead times, pressuring pricing models and forcing manufacturers to secure diversified supply chains.

Rising competition from laboratory‑based LC‑MS/MS services compels kit makers to enhance sensitivity and user experience, lest they lose market share despite the expanding Mycotoxin Test Kit market.

Market Segmentation

Loading chart…

The Application segment delineates the end‑use environments where Mycotoxin Test Kit segmentation drives demand. In the food‑safety arena, kits are employed for rapid screening of cereals, nuts, and processed foods, accounting for the largest share due to stringent regulatory limits on aflatoxin, ochratoxin and related contaminants. The feed‑safety sub‑segment targets livestock rations, where mycotoxin exposure directly impacts animal health and productivity; its growth is propelled by rising awareness of mycotoxin‑induced feed‑conversion losses. Environmental‑monitoring applications involve soil, water and air sampling to assess contamination pathways, supporting preventive measures in agricultural supply chains. Finally, clinical diagnostics, though a niche, utilizes kits to detect mycotoxin metabolites in human biological fluids for exposure assessment. Collectively, these application categories shape the market size by aligning product development, pricing strategies, and distribution channels with the specific compliance and risk‑management needs of each sector.

The Types segment classifies Mycotoxin Test Kits by detection methodology and format, each contributing distinct value propositions to the overall market. Immunoassay‑based kits, such as lateral‑flow devices and ELISA plates, dominate due to their ease of use, low equipment cost, and suitability for on‑site screening; they are favored in both food and feed testing where high throughput is essential. Chromatography‑coupled kits, including LC‑MS/MS and HPLC kits, offer superior specificity and multi‑mycotoxin quantification, commanding premium pricing for regulatory laboratories requiring confirmatory analysis. Biosensor kits, leveraging electrochemical or optical transducers, represent an emerging niche with rapid readouts and potential for integration into digital monitoring platforms. Each type’s market contribution is determined by factors such as required sensitivity, operational complexity, and end‑user budget, thereby influencing adoption rates across the application spectrum.

Mycotoxin Test Kit Segmentation Breakdown11 items

Application

Aflatoxin

Ochratoxin

Fumonisin

Vomitoxin (DON)

Zearalenone

T-2/HT-2 Toxin

Others

Types

ELISA

Lateral Flow

Regional Insights

Loading chart…

The Mycotoxin Test Kit market growth remains anchored by North America, which retains the largest global share, while Asia Pacific is projected as the fastest‑growing region in the forthcoming regional forecast, driven by expanding agricultural output and tightening food‑safety standards.

In North America, stringent FDA and CFIA regulations compel grain processors and livestock feed manufacturers to adopt rapid test kits, while high capital expenditure on advanced analytics and strong R&D pipelines from leading biotech firms further accelerate market penetration and product diversification.

Across Europe, the EU’s comprehensive food‑safety directives, coupled with a mature laboratory infrastructure and robust cross‑border trade compliance mechanisms, stimulate consistent demand; additionally, heightened consumer awareness of mycotoxin health impacts fuels investments in on‑site testing solutions.

The Asia Pacific landscape is propelled by rapid agricultural expansion in China, India, and Southeast Asia, generous government subsidies for food‑safety technologies, and escalating export‑market requirements that mandate stringent mycotoxin monitoring, thereby driving swift adoption of portable test kits.

In Latin America and the Middle East & Africa, growing awareness of mycotoxin hazards, increasing public‑health campaigns, and targeted infrastructure investments—particularly in Brazil, Mexico, Saudi Arabia, and South Africa—are gradually maturing testing ecosystems and opening new growth avenues.

Competitive Landscape

The Mycotoxin Test Kit competitive landscape is characterized by a fragmented supplier base, with a mix of multinational corporations and regionally focused firms. Global players leverage extensive R&D budgets and cross‑border regulatory approvals, while local companies compete on price and proximity to end‑users. Competitive levers revolve around pricing elasticity, breadth of distribution networks, speed of product innovation, and possession of certifications such as ISO 17025 or FDA clearance. Because many kits must meet diverse national residue limits, regulatory approvals serve as a differentiator. Consequently, the market remains moderately consolidated, with no single entity commanding a dominant share.

Key competitive strategies include targeted M&A to acquire niche technologies, strategic partnerships with agricultural cooperatives, and accelerated product launches that address emerging mycotoxin concerns. Firms also pursue geographic expansion, localized manufacturing, and R&D pipelines aimed at multiplex or rapid‑read formats. Differentiation is achieved through proprietary detection chemistries, value‑added service models, strong channel relationships, and cost‑advantage positioning. However, participants face mounting margin pressure from commoditization and rising compliance costs associated with evolving safety standards, which can erode profitability unless offset by scale or innovation.

EnviroLogix, Inc. – regional expansion into Southeast Asia.

Romer Labs – premium pricing for high‑sensitivity kits.

RealTime Laboratories – OEM tie‑ups with agricultural equipment manufacturers.

Scigiene Corporation – innovation pipeline focused on multiplex detection.

Calibre Control International – local manufacturing to reduce supply chain risk.

Generon – vertical integration of assay development and distribution.

Key Mycotoxin Test Kit Companies16 items

EnviroLogix, Inc.

Romer Labs

RealTime Laboratories

Scigiene Corporation

Calibre Control International

Generon

VICAM

Elabscience

Asianmedic

Ergopathics

Gold Standard Diagnostics

Seedburo

Beacon Analytical Systems

AMPCS Ltd

BALLYA

Cusabio Technology

Market Ecosystem

The Mycotoxin Test Kit ecosystem spans from upstream raw‑material sourcing through midstream kit assembly to downstream deployment in food safety and agricultural testing environments. Upstream, specialty chemical producers supply antibodies, enzymes, and membrane materials that determine assay sensitivity. Midstream, original equipment manufacturers and technology providers integrate these inputs into standardized kits, embed detection hardware, and certify performance against regulatory benchmarks. Downstream, distributors deliver the kits to laboratories, processing plants, and field inspection services, where end users conduct rapid screening to mitigate mycotoxin contamination risks. Revenue streams also include recurring consumables such as calibration standards and proprietary reagents, extending the economic relationship beyond the initial kit purchase. Data generated by connected kits can be aggregated for trend analysis, creating ancillary value for both manufacturers and end‑users.

Raw material suppliers — provide antibodies, enzymes, and membrane substrates for assay construction.

Kit manufacturers (OEMs) — assemble components into validated Mycotoxin Test Kits.

Technology providers — develop detection platforms (ELISA, lateral flow, biosensor) integrated into kits.

System integrators — combine hardware, software, and sample preparation modules for turnkey solutions.

Distributors / channel partners — manage regional logistics, inventory, and sales to laboratories and field users.

Service providers — offer calibration, training, and after‑sales technical support for kit performance.

End users — laboratories, food processors, and regulatory agencies conducting on‑site mycotoxin screening.

Adoption hinges on regulators and standards bodies, whose approval criteria shape kit design and drive purchasing decisions. Dependency risks arise from limited antibody suppliers and stringent validation protocols, creating potential bottlenecks for manufacturers. High switching costs—linked to method validation, staff training, and data integration—encourage long‑term partnerships between kit makers and distributors. Interoperability requirements between detection hardware and laboratory information systems further lock in specific providers. In regions with stringent maximum residue limits, government procurement programs become primary demand drivers, concentrating influence with public agencies. Conversely, markets with fragmented standards rely more heavily on private certification schemes, shifting bargaining power toward large distributors and service networks.

Recent Industry Insights

The past year has accelerated transformation across the Mycotoxin Test Kit market, as stakeholders respond to tighter food‑safety mandates and rising demand for rapid, on‑site screening. Companies are leveraging strategic alliances and tech upgrades to broaden assay portfolios, while investors pour capital into next‑generation biosensors. These dynamics are reshaping the competitive landscape and signal a robust growth trajectory for the Mycotoxin Test Kit industry trends.

AcerBio partnered with AgriSense in Q2 2023 to co‑develop a multiplex lateral‑flow kit that detects aflatoxin, ochratoxin and deoxynivalenol within 10 minutes.

Eurofins Scientific acquired Swiss‑based bio‑analytics firm BioQuant for $78 million, adding a proprietary immuno‑chromatographic platform to its portfolio.

Neogen launched the MycoSure™ 2.0, a handheld device integrating AI‑driven image analysis to improve detection limits by 30 %.

The EU Commission revised Regulation (EC) No 1881/2006 in early 2024, lowering permissible aflatoxin B1 levels in infant formula, prompting manufacturers to adopt more sensitive kits.

VC firm AgriVentures led a $45 million Series B round for startup MycoDetect, enabling expansion of its cloud‑connected testing network across Southeast Asia.

Analyst Overview

Overall, the Mycotoxin Test Kit market remains attractive due to sustained regulatory pressure and expanding food‑safety budgets across North America, Europe and emerging Asian economies. Competitive intensity is moderate; a handful of incumbents dominate with differentiated immunoassay platforms while new entrants leverage portable biosensor technologies, keeping pricing pressure modest. The long‑term outlook is positive, with CAGR projected above 7% through 2032 as supply‑chain transparency demands intensify. Innovation is concentrated on multiplexed assays, digital read‑out integration, and rapid‑sample‑prep chemistries, which are shortening time‑to‑result and expanding end‑user segments. Demand continues to outpace supply, driven by stricter mycotoxin limits and increasing awareness among grain processors; manufacturers are scaling production capacity but face raw‑material constraints for antibodies and nanomaterials. Key risks include regulatory shifts, volatile raw‑material pricing, and potential consolidation that could reduce market elasticity. The Mycotoxin Test Kit market outlook suggests robust growth for stakeholders who invest in R&D and agile distribution networks.

12 items

1. Executive Summary

2. Mycotoxin Test Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Mycotoxin Test Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Mycotoxin Test Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Mycotoxin Test Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Mycotoxin Test Kit Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Mycotoxin Test Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Mycotoxin Test Kit Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Mycotoxin Test Kit Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Mycotoxin Test Kit Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Mycotoxin Test Kit Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Mycotoxin Test Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Mycotoxin Test Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Mycotoxin Test Kit Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Mycotoxin Test Kit Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Mycotoxin Test Kit Market Competition by Key Manufacturers

9.1. Global Mycotoxin Test Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Mycotoxin Test Kit: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. EnviroLogix, Inc.

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Romer Labs

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. RealTime Laboratories

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Scigiene Corporation

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Calibre Control International

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Generon

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. VICAM

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Elabscience

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Asianmedic

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Ergopathics

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Gold Standard Diagnostics

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Seedburo

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Beacon Analytical Systems

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. AMPCS Ltd

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. BALLYA

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Cusabio Technology

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Mycotoxin Test Kit Market

Figure 4: Global Mycotoxin Test Kit Market: Drivers

Figure 5: Global Mycotoxin Test Kit Market: Challenges

Figure 6: Global Mycotoxin Test Kit Market: Trends

Figure 7: Global Mycotoxin Test Kit Market: Opportunity

Figure 8: Global Mycotoxin Test Kit Market: Restraint

Figure 9: Global Mycotoxin Test Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Mycotoxin Test Kit Market Value (USD Million) By Region

Figure 19: Global Mycotoxin Test Kit Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Mycotoxin Test Kit Market Value (USD Million) By Region

Figure 27: Global Mycotoxin Test Kit Market Share (%) By: Regions (2032)

Figure 28: Global Mycotoxin Test Kit Market Volume (K) By Region

Figure 29: Global Mycotoxin Test Kit Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Mycotoxin Test Kit Market Value (USD Million) By Region

Figure 37: Global Mycotoxin Test Kit Market Share (%) By: Regions (2032)

Figure 38: Global Mycotoxin Test Kit Market Volume (K) By Region

Figure 39: Global Mycotoxin Test Kit Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

127 items

Table 1: Market Segmentation Analysis

Table 2: Global Mycotoxin Test Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Mycotoxin Test Kit Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Mycotoxin Test Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Mycotoxin Test Kit Market Value (USD Million) By Region

Table 14: Global Mycotoxin Test Kit Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Mycotoxin Test Kit Market Volume (K) By Region

Table 31: Global Mycotoxin Test Kit Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Mycotoxin Test Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Mycotoxin Test Kit Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Mycotoxin Test Kit Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: EnviroLogix, Inc. Basic Information And Sales Area

Table 52: EnviroLogix, Inc.. Products Portfolio

Table 53: Romer Labs Basic Information And Sales Area

Table 54: Romer Labs. Products Portfolio

Table 55: RealTime Laboratories Basic Information And Sales Area

Table 56: RealTime Laboratories. Products Portfolio

Table 57: Scigiene Corporation Basic Information And Sales Area

Table 58: Scigiene Corporation. Products Portfolio

Table 59: Calibre Control International Basic Information And Sales Area

Table 60: Calibre Control International. Products Portfolio

Table 61: Generon Basic Information And Sales Area

Table 62: Generon. Products Portfolio

Table 63: VICAM Basic Information And Sales Area

Table 64: VICAM. Products Portfolio

Table 65: Elabscience Basic Information And Sales Area

Table 66: Elabscience. Products Portfolio

Table 67: Asianmedic Basic Information And Sales Area

Table 68: Asianmedic. Products Portfolio

Table 69: Ergopathics Basic Information And Sales Area

Table 70: Ergopathics. Products Portfolio

Table 71: Gold Standard Diagnostics Basic Information And Sales Area

Table 72: Gold Standard Diagnostics. Products Portfolio

Table 73: Seedburo Basic Information And Sales Area

Table 74: Seedburo. Products Portfolio

Table 75: Beacon Analytical Systems Basic Information And Sales Area

Table 76: Beacon Analytical Systems. Products Portfolio

Table 77: AMPCS Ltd Basic Information And Sales Area

Table 78: AMPCS Ltd. Products Portfolio

Table 79: BALLYA Basic Information And Sales Area

Table 80: BALLYA. Products Portfolio

Table 81: Cusabio Technology Basic Information And Sales Area

Table 82: Cusabio Technology. Products Portfolio

Table 83: Global Market Value (USD Million) (2025-2032) By Application

Table 84: Global Market Share (%) By Application (2032)

Table 85: Global Market Value (USD Million) (2025-2032) By Types

Table 86: Global Market Share (%) By Types (2032)

Table 87: Global Market Volume (K) (2025-2032) By Application

Table 88: Global Market Share (%) By Application (2032)

Table 89: Global Market Volume (K) (2025-2032) By Types

Table 90: Global Market Share (%) By Types (2032)

Table 91: Global Mycotoxin Test Kit Market Value (USD Million) By Region

Table 92: Global Mycotoxin Test Kit Market Share (%) By Region (2025-2032)

Table 93: North America Market Value (USD Million) (2025-2032) By Country

Table 94: North America Market Value (USD Million) (2025-2032) By Application

Table 95: North America Market Value (USD Million) (2025-2032) By Types

Table 96: Europe Market Value (USD Million) (2025-2032) By Country

Table 97: Europe Market Value (USD Million) (2025-2032) By Application

Table 98: Europe Market Value (USD Million) (2025-2032) By Types

Table 99: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 100: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 101: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 102: South America Market Value (USD Million) (2025-2032) By Country

Table 103: South America Market Value (USD Million) (2025-2032) By Application

Table 104: South America Market Value (USD Million) (2025-2032) By Types

Table 105: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 106: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 107: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 108: Global Mycotoxin Test Kit Market Volume (K) By Region

Table 109: Global Mycotoxin Test Kit Market Share (%) By Region (2025-2032)

Table 110: North America Market Volume (K) (2025-2032) By Country

Table 111: North America Market Volume (K) (2025-2032) By Application

Table 112: North America Market Volume (K) (2025-2032) By Types

Table 113: Europe Market Volume (K) (2025-2032) By Country

Table 114: Europe Market Volume (K) (2025-2032) By Application

Table 115: Europe Market Volume (K) (2025-2032) By Types

Table 116: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 117: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 118: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 119: South America Market Volume (K) (2025-2032) By Country

Table 120: South America Market Volume (K) (2025-2032) By Application

Table 121: South America Market Volume (K) (2025-2032) By Types

Table 122: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 123: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 124: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 125: Research Programs/Design For This Report

Table 126: Key Data Information From Secondary Sources

Table 127: Key Data Information From Primary Sources

FAQs

1. What is the current Mycotoxin Test Kit market size?

The Mycotoxin Test Kit market size reached approximately USD 1.15 billion in 2023, driven by heightened food safety concerns and expanding testing requirements across agricultural and feed sectors worldwide, including increased adoption in emerging economies and rising demand for rapid, on‑site detection solutions.

2. What is the growth forecast and future outlook for the market?

Analysts project a robust future outlook, with the market expected to expand at a compound annual growth rate of 6.2 % between 2024 and 2032, reaching roughly USD 1.9 billion by the end of the forecast period.

3. What are the key drivers behind market expansion?

Key drivers include stricter food‑borne toxin regulations, rising consumer awareness of mycotoxin health risks, growth in global grain trade, and increasing investment by agribusinesses in rapid, cost‑effective screening technologies to protect supply‑chain integrity and to meet export certification requirements.

4. What challenges could impede market growth?

Challenges stem from high initial kit costs, limited sensitivity of some lateral‑flow formats, fragmented distribution networks in low‑income regions, and the need for skilled personnel to interpret complex ELISA or LC‑MS data, which can slow adoption.

5. Which regions are leading the Mycotoxin Test Kit market?

North America remains the largest contributor, driven by extensive research activities, while Europe follows closely due to rigorous safety standards. Asia‑Pacific is the fastest‑growing region, propelled by expanding cereal production and increasing regulatory enforcement across China, India, and Southeast Asia.

6. Who are the top companies operating in this market?

Leading players include Eurofins Scientific, Neogen Corporation, R-Biopharm AG, Bio‑Rad Laboratories, and Romer Labs. These firms differentiate through integrated platforms, extensive product portfolios, and strategic partnerships that enhance global reach and customer support services across multiple segments.

7. What future opportunities exist for market participants?

Future opportunities arise from the rise of multiplex assay kits, integration of IoT‑enabled data analytics, growing demand for on‑farm testing solutions, and expanding applications in pet food, biofuels, and pharmaceutical raw material verification, which will drive higher adoption rates globally.

8. How is technology impacting the Mycotoxin Test Kit market?

Advances in biosensor design, portable spectrometry, and CRISPR‑based detection are reducing assay time and improving sensitivity, enabling real‑time monitoring. Digital platforms also streamline result reporting, fostering greater integration with supply‑chain management systems and facilitating compliance verification for exporters.

9. What is the regulatory landscape shaping the market?

Regulatory frameworks such as the EU Mycotoxin Regulation, FDA guidance on food safety, and Codex Alimentarius limits compel manufacturers to adopt validated test kits. Ongoing revisions are expected to tighten permissible levels, further stimulating market demand.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Mycotoxin Test Kit Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.25 billion
Revenue forecast in 2033	2.19 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	EnviroLogix, Inc.; Romer Labs; RealTime Laboratories; Scigiene Corporation; Calibre Control International; Generon; VICAM; Elabscience; Asianmedic; Ergopathics; Gold Standard Diagnostics; Seedburo; Beacon Analytical Systems; AMPCS Ltd; BALLYA; Cusabio Technology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options